Surgical Treatments for Advanced Heart Failure

Surgical Clinics of North America

Volumn 89, Issue 4, 2009, Pages 967-999

  Daneshmand, Mani A ^a   Milano, Carmelo A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heart failure; Immunosuppression; Surgical ventricular restoration; Transplantation; Ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMIODARONE; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN INHIBITOR; CLENBUTEROL; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; DOBUTAMINE; DOXORUBICIN; ILOPROST; INOTROPIC AGENT; LIDOCAINE; METHYLPREDNISOLONE; MILRINONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; OKT 3; THYMOCYTE ANTIBODY; WARFARIN;

AORTA CLAMPING; CARDIOPULMONARY BYPASS; CARDIOTOXICITY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS SURGERY; DEVICE INFECTION; DISEASE SEVERITY; DONOR SELECTION; ENDOCARDITIS; GASTROINTESTINAL HEMORRHAGE; GRAFT FAILURE; HEART ASSIST DEVICE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; ORGAN PRESERVATION; PATIENT SELECTION; PERIPHERAL EDEMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; SURGICAL VENTRICULAR RESTORATION; SURVIVAL RATE;

HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; IMMUNOSUPPRESSION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349316557     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2009.06.007     Document Type: Review

References (101)

1. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106 (2002) 3068-3072
3. O'Connor C., Gattis W., Zannad F., et al. Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes. Eur J Heart Fail 1 (1999) 81-88
4. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
5. Califf R.M., Adams K.F., McKenna W.J., et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 134 (1997) 44-54
6. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325 (1991) 293-302
7. Packer M., Coats A.J.S., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
8. Barnard C. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur hospital, Cape Town. S Afr Med J 41 (1967) 1271-1274
9. Dong E., Lower R.R., Hurley E.J., et al. Transplantation of the heart. Dis Chest 48 (1965) 455-457
10. Shumway N.E., Lower R.R., and Angell W.W. Present status of cardiac transplantation. Angiology 17 (1966) 289-291
11. Cooley D.A., Bloodwell R.D., Hallman G.L., et al. Transplantation of the human heart. Report of four cases. JAMA 205 (1968) 479-486
12. Cooley D.A. The first implantation of an artificial heart: reflections and observations. Transplant Proc 5 (1973) 1135-1137
13. DeBakey M.E. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol 27 (1971) 3-11
14. DeBakey M.E., and Kennedy J.H. Mechanical circulatory support: current status. Am J Cardiol 27 (1971) 1-2
15. Batista R.J., Santos J.L., Takeshita N., et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 11 (1996) 96-97 [discussion 98]
16. McCarthy M. Batista procedure proves its value in the USA. Lancet 349 (1997) 855
17. McCarthy J.F., McCarthy P.M., Starling R.C., et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg 13 (1998) 337-343
18. McCarthy P.M., Starling R.C., Young J.B., et al. Left ventricular reduction surgery with mitral valve repair. J Heart Lung Transplant 19 (2000) 564-567
19. Starling R.C., McCarthy P.M., Buda T., et al. Results of partial left ventriculectomy for dilated cardiomyopathy - hemodynamic, clinical and echocardiographic observations. J Am Coll Cardiol 36 (2000) 2098-2103
20. Franco-Cereceda A., McCarthy P.M., Blackstone E.H., et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation?. J Thorac Cardiovasc Surg 121 (2001) 879-893
21. Batista R.J.V., Verde J., Nery P., et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 64 (1997) 634-638
22. Dor V., Saab M., Coste P., et al. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 37 (1989) 11-19
23. Dor V. Left ventricular restoration by endoventricular circular patch plasty (EVCPP). Z Kardiol 89 (2000) 70-75
24. Dor V., Montiglio F., Sabatier M., et al. Left ventricular shape changes induced by aneurysmectomy with endoventricular circular patch plasty reconstruction. Eur Heart J 15 (1994) 1063-1069
25. Athanasuleas C.L., Buckberg G.D., Stanley A.W.H., et al. Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev 9 (2005) 287-297
26. Velazquez E.J., Lee K.L., O'Connor C.M., et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 134 (2007) 1540-1547
27. Jones R.H., Velazquez E.J., Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360 (2009) 1705-1717
28. Harrison J., Califf R., Woodlief L., et al. Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group. Circulation 87 (1993) 1531-1541
29. Dor V. Surgical remodeling of left ventricle. Surg Clin North Am 84 (2004) 27-43
30. Gaudron P., Eilles C., Kugler I., et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87 (1993) 755-763
31. Diwan A., Krenz M., Syed F.M., et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 117 (2007) 2825-2833
32. Hayakawa Y., Chandra M., Miao W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of G{alpha}q transgenic mice. Circulation 108 (2003) 3036-3041
33. Dor V., Civaia F., Alexandrescu C., et al. The post-myocardial infarction scarred ventricle and congestive heart failure: the preeminence of magnetic resonance imaging for preoperative, intraoperative, and postoperative assessment. J Thorac Cardiovasc Surg 136 (2008) 1405-1412
34. Ailawadi G., and Kron I.L. New strategies for surgical management of ischemic cardiomyopathy. Expert Rev Cardiovasc Ther 6 (2008) 521-530
35. Patel N.D., Williams J.A., Nwakanma L.U., et al. Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?. Ann Thorac Surg 82 (2006) 879-888
36. Williams J., Patel N., Nwakanma L., et al. Outcomes following surgical ventricular restoration in elderly patients with congestive heart failure. Am J Geriatr Cardiol 16 (2007) 67-75
37. Menicanti L., Donato M.D., Castelvecchio S., et al. Functional ischemic mitral regurgitation in anterior ventricular remodeling: results of surgical ventricular restoration with and without mitral repair. Heart Fail Rev 9 (2005) 317-327
38. Lee S., Chang B.-C., Youn Y.-N., et al. Changes in left ventricular function and dimension after surgical ventricular restoration with or without concomitant mitral valve procedure. Circ J 71 (2007) 1516-1520
39. Di Donato M., Castelvecchio S., Brankovic J., et al. Effectiveness of surgical ventricular restoration in patients with dilated ischemic cardiomyopathy and unrepaired mild mitral regurgitation. J Thorac Cardiovasc Surg 134 (2007) 1548-1553
40. Milano C.A., Daneshmand M.A., Rankin J.S., et al. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg 86 (2008) 735-744
41. Maxey T.S., Reece T.B., Ellman P.I., et al. The beating heart approach is not necessary for the Dor procedure. Ann Thorac Surg 76 (2003) 1571-1575
42. Icenogle T.B., Williams R.J., Smith R.G., et al. Extracorporeal pulsatile biventricular support after cardiac transplantation. Ann Thorac Surg 47 (1989) 614-616
43. Esmore D., Spratt P., Branch J., et al. Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance. J Heart Transplant 9 (1990) 136-141
44. Grinda J.-M., Chevalier P., D'Attellis N., et al. Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery. Eur J Cardiothorac Surg 26 (2004) 1169-1173
45. Farrar D.J., Holman W.R., McBride L.R., et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21 (2002) 516-521
46. Acker M.A. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 71 (2001) S73-S76
47. Hill J., Farrar D., Hershon J., et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 314 (1986) 626-628
48. Starnes V., Oyer P., Portner P., et al. Isolated left ventricular assist as bridge to cardiac transplantation. J Thorac Cardiovasc Surg 96 (1988) 62-71
49. Aaronson K.D., Eppinger M.J., Dyke D.B., et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 39 (2002) 1247-1254
50. Omoto R., Kyo S., Nishimura M., et al. Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs 8 (2005) 34-40
51. Holmes E. Outpatient management of long-term assist devices. Cardiol Clin 21 (2003) 93-99
52. Kherani A.R., and Oz M.C. Ventricular assistance to bridge to transplantation. Surg Clin North Am 84 (2004) 75-89
53. Monkowski D.H., Axelrod P., Fekete T., et al. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 9 (2007) 114-120
54. Oz M., Argenziano M., Catanese K.A., et al. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation?. Circulation 95 (1997) 1844-1852
55. Felker G.M., and Rogers J.G. Same bridge, new destinations: rethinking paradigms for mechanical cardiac support in heart failure. J Am Coll Cardiol 47 (2006) 930-932
56. 2007 Annual Report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: transplant data 1997-2006, in Health Resources and Services Administration HSB, Division of Transplantation (ed). Rockville (MD), 2007.
57. Investigators TE, ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE Trial. JAMA 294 (2005) 1625-1633
58. Klein M., and Gold M. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Cardiol Clin 26 (2008) 419-431
59. Albright C., Quinn T., Berberian G., et al. Measurement of QRS duration for biventricular pacing optimization. ASAIO J 54 (2008) 335-340
60. Reuter S., Garrigue S., Bordachar P., et al. Intermediate-term results of biventricular pacing in heart failure: correlation between clinical and hemodynamic data. Pacing Clin Electrophysiol 23 (2000) 1713-1717
61. Daneshmand M.A., Blue L., Farrar D.J., et al. BMI does not affect outcomes in destination therapy LVAD. ASAIO J 54 (2008) 42
62. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
63. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
64. Lietz K., and Miller L.W. Destination therapy: current results and future promise. Semin Thorac Cardiovasc Surg 20 (2008) 225-233
65. HeartMate best practice guidelines (2008), Thoratec Corporation, Pleasanton (CA)
66. Pal J.D., Klodell C.T., John R., et al. Abstract 5857: low operative mortality with implantation of a continuous flow LVAD and impact of concurrent cardiac procedures. Circulation 118 (2008) S1017
67. Fukamachi K., McCarthy P.M., Smedira N.G., et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 68 (1999) 2181-2184
68. Argenziano M., Choudhri A.F., Moazami N., et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 65 (1998) 340-345
69. Yin N., Kaestle S., Yin J., et al. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease. Crit Care Med 37 (2009) 980-986
70. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33 (2008) 679-684
71. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., et al. Mechanical unloading restores {beta}-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
72. Long J.W., Healy A.H., Rasmusson B.Y., et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg 135 (2008) 1353-1361
73. Martin J., Friesewinkel O., Benk C., et al. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. J Heart Lung Transplant 25 (2006) 384-390
74. John R., Kamdar F., Liao K., et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86 (2008) 1227-1235
75. Frazier O., Gemmato C., Myers T., et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 34 (2007) 275-281
76. John R., Kamdar F., Liao K., et al. Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 136 (2008) 1318-1323
77. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
78. Yaoita H., and Maruyama Y. Intervention for apoptosis in cardiomyopathy. Heart Fail Rev 13 (2008) 181-191
79. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
80. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 25 (2006) 1024-1042
81. Mancini D., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
82. Yang J., Schall C., Smith D., et al. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of luminex. J Heart Lung Transplant 28 (2009) 123-129
83. Baldwin J., Anderson J., Boucek M., et al. 24th Bethesda conference: cardiac transplantation. Task Force 2: donor guidelines. J Am Coll Cardiol 22 (1993) 15-20
84. Weiss E.S., Nwakanma L.U., Russell S.B., et al. Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 27 (2008) 178-183
85. Stobierska-Dzierzek B., Awad H., and Michler R.E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38 (2001) 923-931
86. Miniati D.N., and Robbins R.C. Heart transplantation: a thirty-year perspective. Annu Rev Med 53 (2002) 189
87. Carrier M., Blaise G., Bélisle S., et al. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 18 (1999) 664-667
88. George S., and Boscoe M. Inhaled nitric oxide for right ventricular dysfunction following cardiac transplantation. Br J Clin Pract 51 (1997) 53-55
89. Whyte R.I., Deeb G.M., McCurry K.R., et al. Extracorporeal life support after heart or lung transplantation. Ann Thorac Surg 58 (1994) 754-758
90. Barzaghi N., Olivei M., Minzioni G., et al. ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation. Ann Thorac Surg 63 (1997) 533-535
91. Zhang R., Haverich A., Strüber M., et al. Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin. J Heart Lung Transplant 27 (2008) 603-609
92. Goland S., Czer L.S.C., Coleman B., et al. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant 27 (2008) 1115-1121
93. Chou N.K., Wang S.S., Chen Y.S., et al. Induction immunosuppression with basiliximab in heart transplantation. Transplant Proc 40 (2008) 2623-2625
94. Baran D.A. Induction therapy in cardiac transplantation: when and why?. Heart Fail Clin 3 (2007) 31-41
95. Mattei M.F., Redonnet M., Gandjbakhch I., et al. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy. J Heart Lung Transplant 26 (2007) 693-699
96. Crespo-Leiro M.G., Alonso-Pulpón L., Arizón J.M., et al. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish post-heart transplant tumour registry. J Heart Lung Transplant 26 (2007) 1105-1109
97. McLean M.K., and Barr M.L. Current state of heart transplantation. Transplantation Updates 2 (2008) 3-10
98. Eisen H.J., Kobashigawa J., Keogh A., et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 517-525
99. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
100. Lima B., Rajagopal K., Petersen R.P., et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation 114 (2006) I27-I32
101. Felker G.M., Milano C.A., Yager J.E.E., et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant 24 (2005) 1781-1786